Newsletter Signup
join our mailing list

Ads by Google

What would you like to see happen with CAM products in the future? How could it be controlled more effectively?

Controls should be in place to verify that doses contained in the products are adequate to deliver on the promised label claim, ie that the product does not contain sub-therapeutic doses. Furthermore products should be compelled to be manufactured in facilities that are licensed to manufacture medicines and that adhere to GMP (good manufacturing practice). This would ensure consistent high quality products. Many manufacturers maintain their products are “foods” and thus that they don’t require manufacturing in pharmaceutically licensed facilities, but can rather be made in food factories. This should stop. There are some manufacturers, such as Solal Technologies, that do manufacture their complementary medicines in pharmaceutically licensed facilities, but many don’t. This can easily be regulated by new regulations, which are apparently being drafted.

Share this page on facebook